Tahir Sophia, Ashraf Naufin N, Elessawy Hashem, Khan Sohail, Hamad Samah Badr, Khan Waqar
Internal Medicine, Windsor University School of Medicine, Basseterre, KNA.
Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
Cureus. 2024 Aug 31;16(8):e68354. doi: 10.7759/cureus.68354. eCollection 2024 Aug.
Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a low platelet count, which can lead to increased bleeding and bruising. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organ systems and often presents with various hematologic abnormalities, including thrombocytopenia. A 32-year-old woman presented to the emergency department with petechiae, extensive ecchymosis, rectal bleeding, generalized body aches, anorexia, and weakness. Despite showing no clinical features of SLE, laboratory findings revealed severe thrombocytopenia and anemia. Initial treatment with low-dose steroids showed no improvement, but a high-dose steroid regimen significantly increased her platelet count. Further investigations revealed elevated ANA and positive anti-dsDNA, leading to a diagnosis of isolated thrombocytopenia as the initial manifestation of SLE. The subsequent findings of elevated ANA and positive anti-dsDNA confirmed the diagnosis of SLE, with ITP as its initial manifestation. This case underscores the importance of considering underlying autoimmune diseases in patients presenting with isolated thrombocytopenia after ruling out other causes. Early recognition and appropriate treatment of autoimmune conditions like SLE can significantly improve patient outcomes, even when initial presentations are atypical.
免疫性血小板减少性紫癜(ITP)是一种自身免疫性疾病,其特征为血小板计数低,可导致出血和瘀伤增加。系统性红斑狼疮(SLE)是一种慢性自身免疫性疾病,可影响多个器官系统,常表现出各种血液学异常,包括血小板减少症。一名32岁女性因出现瘀点、广泛瘀斑、直肠出血、全身疼痛、厌食和虚弱而就诊于急诊科。尽管未表现出SLE的临床特征,但实验室检查结果显示严重血小板减少和贫血。低剂量类固醇的初始治疗未见改善,但高剂量类固醇方案显著提高了她的血小板计数。进一步检查发现抗核抗体(ANA)升高和抗双链DNA(anti-dsDNA)阳性,从而诊断为以孤立性血小板减少症为SLE初始表现。随后ANA升高和anti-dsDNA阳性的检查结果证实了SLE的诊断,其初始表现为ITP。该病例强调了在排除其他原因后,对于出现孤立性血小板减少症的患者考虑潜在自身免疫性疾病的重要性。即使初始表现不典型,对SLE等自身免疫性疾病的早期识别和适当治疗也可显著改善患者预后。